Monitor future Form 4 filings for actual option exercises or stock sales, which could signal insider sentiment. The current filings are administrative and not indicative of trading activity.
Price Chart
Executive Summary
Kailera Therapeutics executives Ronald C. Renaud Jr. and Paula Cloghessy filed initial Form 3s disclosing stock option grants and established powers of attorney to facilitate future SEC filings. These are routine compliance filings related to equity compensation and do not reflect changes in beneficial ownership or immediate transactions.
Key Facts
- Ronald C. Renaud Jr., CEO & President, filed Form 3 disclosing multiple stock options with exercise prices ranging from $5.25 to $7.24, vesting through 2035.
- Paula Cloghessy, Chief People Officer, filed Form 3 disclosing stock options with exercise prices of $5.25 to $7.24, vesting through 2035.
- Both executives appointed Scott Akamine, John Mei, and Corey Manchester as attorneys-in-fact to file future Section 16 reports on their behalf.
- No shares were bought or sold; these are initial disclosures of previously granted equity awards.
Financial Impact
No immediate financial impact. These filings disclose existing stock options but do not involve new issuances, exercises, or sales.
Risk Factors
- Potential for future dilution if options are exercised.
- No material risk from these filings alone, but absence of insider buying may suggest lack of conviction.
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (KLRA) — Batch item 1 | 0001193125-26-159656 |
| Document: 0001193125-26-159656-index-headers.html | 0001193125-26-159657 |
| Document: 0001193125-26-159656-index.html | 0001193125-26-159656 |
| Document: 0001193125-26-159656.txt | 0001193125-26-159656 |
| 3 Filing (KLRA) — Batch item 5 | 0001193125-26-159657 |
| Document: 0001193125-26-159657-index-headers.html | 0001193125-26-159656 |
| Document: 0001193125-26-159657-index.html | 0001193125-26-159656 |
| Document: 0001193125-26-159657.txt | 0001193125-26-159656 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | 3 | $14.91 $12.92 | ▼ −13.35% | ▼ −12.85% | $10.39 (−30.32%) |
Aug 12, 2026 7w ago | 8-K | $17.97 $17.47 | ▼ −2.78% | ▼ −0.82% | $10.39 (−42.18%) |
Jul 31, 2026 9w ago | Court Ruling | $16.94 $18.66 | ▲ +10.15% | ▲ +6.64% | $10.39 (−38.67%) |
Jul 24, 2026 10w ago | Court Ruling | $17.69 $17.05 | ▼ −3.62% | ▼ −3.99% | $10.39 (−41.27%) |
Jun 5, 2026 16w ago | Press Release | $19.70 $19.67 | ▼ −0.15% | ▼ −2.26% | $10.39 (−47.26%) |
May 26, 2026 18w ago | 8-K | $21.91 $22.38 | ▲ +2.15% | ▲ +1.68% | $10.39 (−52.58%) |
May 26, 2026 18w ago | Press Release | $21.91 $22.59 | ▲ +3.10% | ▲ +1.90% | $10.39 (−52.58%) |
May 13, 2026 20w ago | Press Release | $21.11 $19.62 | ▼ −7.06% | ▼ −5.90% | $10.39 (−50.78%) |
Apr 20, 2026 23w ago | 8-K | $25.22 $23.82 | ▼ −5.55% | ▼ −6.63% | $10.39 (−58.80%) |
Apr 20, 2026 23w ago | Insider Cluster | $24.61 $23.51 | ▼ −4.47% | ▼ −5.38% | $10.39 (−57.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access